International Immunopharmacology · 2022 · 37 citations · 36 references
MedicineNeurosciencePharmacologyMolecular NeuroscienceNeuroendocrinologyNeuroimmunologyDiabetes MellitusMicroglia BiologyNeurodegenerative DiseasesNeurodegenerative DisordersNeuroinflammationNeuroprotectionChronic NeuroinflammationGlp-1 Receptor PharmacologyLong-acting Glp-1 Receptor AgonistsMicroglial PolarizationNeuroinflammation ModulationObesity-induced InflammationRodent NeuroinflammationSmall-molecule Glp-1 Receptor Agonists
Obesity is associated with multiple comorbidities, such as metabolic abnormalities and cognitive dysfunction. Moreover, accumulating evidence indicates that neurodegenerative disorders are associated with chronic neuroinflammation. GLP-1 receptor agonists (RAs) have been extensively studied as a treatment for type 2 diabetes. Emerging evidence has demonstrated a protective effect of GLP-1 RAs on neurodegenerative disease, which is independent of its glucose-lowering effects. In this study, we aimed to examine the effects of a long-acting GLP-1 RA, exenatide, on high-fat diet (HFD)-induced neuroinflammation and related brain function impairment. First, mice treated with exenatide exhibited significantly reduced HFD-increased body weight and blood glucose. In an open field test, exenatide treatment ameliorated the reduction in local motor activity and anxiety in HFD-fed mice. Moreover, HFD induced astrogliosis, microgliosis, and upregulation of IL-1β, IL-6 and TNF-α in hippocampus and cortex. Exenatide treatment reduced HFD-induced astrogliosis and IL-1β and TNF-α expressions. Moreover, exenatide increased phosphor-ERK and M2-type microglia marker arginase-1 expression in the hippocampus and cortex. In addition, we found that scavenger receptor-A4 protein expression was induced by HFD and was subsequently inhibited by exenatide. SR-A4 knockout reversed the locomotor activity impairment but not the anxiety behavior caused by HFD consumption. SR-A4 knockout also reduced HFD-induced neuroinflammation, as shown by the reduced expression of GFAP and IBA-1 compared with that in wild-type control mice. These results demonstrate that exenatide decreases HFD-increased neuroinflammation and promotes anti-inflammatory M2 differentiation. The inhibition of SR-A4 by exenatide exerts anti-inflammatory activity.
36
Xiaoming Hu, Peiying Li, Yanling Guo et al. · Stroke · 2012 · 1.6K citations · Full text
Medicine, Neurobiology, Neuroscience +17
Anxiety Cells in a Hippocampal-Hypothalamic Circuit
Jessica Jimenez, Katy Su, Alexander Goldberg et al. · Neuron · 2018 · 659 citations · Full text